Table of Contents PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT PART 03: RESEARCH METHODOLOGY PART 04: MARKET LANDSCAPE • Market ecosystem • Market characteristics • Market segmentation analysis PART 05: MARKET SIZING • Market definition • Market sizing 2017 • Market size and forecast 2017-2022 PART 06: FIVE FORCES ANALYSIS • Bargaining power of buyers • Bargaining power of suppliers • Threat of new entrants • Threat of substitutes • Threat of rivalry • Market condition PART 07: MARKET SEGMENTATION BY APPLICATION • Segmentation by application • Comparison by application • Blood glucose testing– Market size and forecast 2017-2022 • Cardiometabolic testing – Market size and forecast 2017-2022 • Infectious disease testing – Market size and forecast 2017-2022 • Pregnancy and fertility testing – Market size and forecast 2017-2022 • Fecal occult testing – Market size and forecast 2017-2022 • Toxicology testing – Market size and forecast 2017-2022 • Coagulation testing – Market size and forecast 2017-2022 • Market opportunity by application PART 08: CUSTOMER LANDSCAPE PART 09: MARKET SEGMENTATION BY END-USER • Segmentation by end-user • Hospitals and clinics • Clinical diagnostic laboratories • Home care settings PART 10: REGIONAL LANDSCAPE • Geographical segmentation • Regional comparison • Rapid diagnostics market in Americas • Rapid diagnostics market in EMEA • Rapid diagnostics market in APAC • Market opportunity PART 11: DECISION FRAMEWORK PART 12: DRIVERS AND CHALLENGES • Market drivers • Market challenges PART 13: MARKET TRENDS • Growing presence of OEMs • Use of digital health in rapid diagnostics for POC • Increasing number of M&A PART 14: VENDOR LANDSCAPE • Overview • Landscape disruption • Competitive landscape PART 15: VENDOR ANALYSIS • Vendors covered • Vendor classification • Market positioning of vendors • Abbott • BD • bioMérieux • Danaher • F. Hoffmann-La Roche • Siemens Healthcare • Other prominent vendors PART 16: APPENDIX • List of abbreviations List of Exhibits Exhibit 01: Global IVD market Exhibit 02: Global IVD market Exhibit 03: Market characteristics Exhibit 04: Market segments Exhibit 05: Market definition - Inclusions and exclusions checklist Exhibit 06: Global rapid diagnostics market size 2017 Exhibit 07: Validation techniques employed for market sizing 2017 Exhibit 08: Global rapid diagnostics market size and forecast 2017-2022 ($ mn) Exhibit 09: Global rapid diagnostics market – Year over year growth 2018-2022 (%) Exhibit 10: Five forces analysis 2017 Exhibit 11: Five forces analysis 2022 Exhibit 12: Bargaining power of buyers Exhibit 13: Bargaining power of suppliers Exhibit 14: Threat of new entrants Exhibit 15: Threat of substitutes Exhibit 16: Threat of rivalry Exhibit 17: Market condition - Five forces 2017 Exhibit 18: Application – Market share 2017-2022 (%) Exhibit 19: Comparison by application Exhibit 20: Blood glucose testing by rapid diagnostics– Market size and forecast 2017-2022 ($ mn) Exhibit 21: Blood glucose testing by rapid diagnostics – Year over year growth 2018-2022 (%) Exhibit 22: Cardiometabolic testing by rapid diagnostics – Market size and forecast 2017-2022 ($ mn) Exhibit 23: Cardiometabolic testing by rapid diagnostics – Year over year growth 2018-2022 (%) Exhibit 24: Infectious disease testing by rapid diagnostics – Market size and forecast 2017-2022 ($ mn) Exhibit 25: Infectious disease testing by rapid diagnostics – Year over year growth 2018-2022 (%) Exhibit 26: Pregnancy and fertility testing by rapid diagnostics – Market size and forecast 2017-2022 ($ mn) Exhibit 27: Pregnancy and fertility testing by rapid diagnostics – Year over year growth 2018-2022 (%) Exhibit 28: Fecal occult testing by rapid diagnostics– Market size and forecast 2017-2022 ($ mn) Exhibit 29: Fecal occult testing by rapid diagnostics – Year over year growth 2018-2022 (%) Exhibit 30: Toxicology testing by rapid diagnostics – Market size and forecast 2017-2022 ($ mn) Exhibit 31: Toxicology testing by rapid diagnostics – Year over year growth 2018-2022 (%) Exhibit 32: Coagulation testing by rapid diagnostics– Market size and forecast 2017-2022 ($ mn) Exhibit 33: Toxicology testing by rapid diagnostics – Year over year growth 2018-2022 (%) Exhibit 34: Market opportunity by application Exhibit 35: Customer landscape Exhibit 36: Global rapid diagnostics market by end-user – Market share 2017 (%) Exhibit 37: Global rapid diagnostics market – Market share by geography 2017-2022 (%) Exhibit 38: Regional comparison Exhibit 39: Rapid diagnostics market in the Americas – Market size and forecast 2017-2022 ($ mn) Exhibit 40: Rapid diagnostics market in the Americas – Year over year growth 2018-2022 (%) Exhibit 41: Top 3 countries in Americas Exhibit 42: Rapid diagnostics market in EMEA – Market size and forecast 2017-2022 ($ mn) Exhibit 43: Rapid diagnostics market in EMEA – Year over year growth 2018-2022 (%) Exhibit 44: Top 3 countries in EMEA Exhibit 45: Rapid diagnostics market in APAC – Market size and forecast 2017-2022 ($ mn) Exhibit 46: Rapid diagnostics market in APAC – Year over year growth 2018-2022 (%) Exhibit 47: Top 3 countries in APAC Exhibit 48: Market opportunity Exhibit 49: Market impact analysis of M&A Exhibit 50: Vendor landscape Exhibit 51: Landscape disruption Exhibit 52: Vendors covered Exhibit 53: Vendor classification Exhibit 54: Market positioning of vendors Exhibit 55: Abbott overview Exhibit 56: Abbott: Business segments Exhibit 57: Abbott: Organizational developments Exhibit 58: Abbott: Geographic focus Exhibit 59: Abbott: Segment focus Exhibit 60: Abbott: Key offerings Exhibit 61: Abbott: Key customers Exhibit 62: BD overview Exhibit 63: BD – Business segments Exhibit 64: BD – Organizational developments Exhibit 65: BD – Geographic focus Exhibit 66: BD – Segment focus Exhibit 67: BD – Key offerings Exhibit 68: BD – Key customers Exhibit 69: bioMérieux: Overview Exhibit 70: bioMérieux: Business segments Exhibit 71: bioMérieux: Organizational developments Exhibit 72: bioMérieux: Geographic focus Exhibit 73: bioMérieux: Segment focus Exhibit 74: bioMérieux: Key offerings Exhibit 75: bioMérieux: Key customers Exhibit 76: Danaher: Overview Exhibit 77: Danaher: Business segments Exhibit 78: Danaher: Organizational developments Exhibit 79: Danaher: Geographic focus Exhibit 80: Danaher: Segment focus Exhibit 81: Danaher: Key offerings Exhibit 82: Danaher: Key customers Exhibit 83: F. Hoffmann-La Roche overview Exhibit 84: F. Hoffmann-La Roche: Business segments Exhibit 85: F. Hoffmann-La Roche: Organizational developments Exhibit 86: F. Hoffmann-La Roche: Geographic focus Exhibit 87: F. Hoffmann-La Roche: Segment focus Exhibit 88: F. Hoffmann-La Roche: Key offerings Exhibit 89: F. Hoffmann-La Roche: Key customers Exhibit 90: Siemens Healthcare: Overview Exhibit 91: Siemens Healthcare: Business segments Exhibit 92: Siemens Healthcare: Organizational developments Exhibit 93: Siemens Healthcare: Geographic focus Exhibit 94: Siemens Healthcare: Segment focus Exhibit 95: Siemens Healthcare: Key offerings Exhibit 96: Siemens Healthcare: Key customers

Abbott, BD, bioMérieux, Danaher, F. Hoffmann -La Roche, and Siemens Healthcare.